Can Deep Learning Survive the Precision Medicine Paradox?
As precision medicine narrows patient cohorts to rare‑disease scales, deep learning models face a paradox of data scarcity and overfitting that threatens the future of clinical AI.
Regulatory & Commercialisation
Navigate the intersection of compliance, market access, and strategic launch planning to bring approved therapies successfully to patients.
No content has been published for this topic yet.
